Strategy & Management

Magazine articles on business strategy, management and leadership.

Old Articles: <Older 15041-15050 Newer>

Fast Company January 9, 2012 Kate Rockwood	Wanted: John & Kira's Handcrafted, Locavore-Friendly Chocolates Philadelphia-based John & Kira's crafts lust-worthy treats using ingredients from local farms and gardens.
HBS Working Knowledge January 9, 2012 Dina Gerdeman	Location, Location, Location: The Strategy of Place Many companies think of geographic strategy as a short-term checkers match rather than as a long-term chess game.
The Motley Fool January 9, 2012 Travis Hoium	TransAtlantic Petroleum Shares Sank: What You Need to Know Shares of oil producer TransAtlantic Petroleum fell as much as 12% today after the company's COO announced he would step down.
The Motley Fool January 9, 2012 Rick Aristotle Munarriz	Reed Hastings: 2012's CEO of the Year? Netflix gets off to a strong start this young year.
The Motley Fool January 8, 2012	Born in the USA, Made in France: How McDonald's Succeeds in the Land of Michelin Stars To make it in France, McDonald's made itself look like a French company and offered French favorites.
Pharmaceutical Executive January 1, 2012 Mason Tenaglia	Letting the Facts Get in the Way An empirical defense of coupons and copay offset programs.
Pharmaceutical Executive January 1, 2012	Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Pharmaceutical Executive January 1, 2012 William Looney	Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Pharmaceutical Executive January 1, 2012 Elys Roberts & Sarah Phillips	The Emergence of the Pro-Patient How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?
Pharmaceutical Executive January 1, 2012 Bill Drummy	Scared to Death The pharma industry's risk-aversion is risking its survival. Where did the courage to innovate go?
<Older 15041-15050 Newer> Return to current articles.